An advisory panel with independent advisors from the Food and Drug Administration (FDA), From United States, issued a recommendation that Pfizer's Covid-19 vaccine be given to children aged 5 to 11 years.

The decision came after a full day of deliberations among experts. However, after much discussion, the technicians concluded that the scientific evidence available from Pfizer have shown that the vaccine has more benefits than risks for children.


The panel is composed of 18 members, none of whom were against the recommendation of the vaccine for children. The final score was 17 votes in favor of the recommendation and one abstention. As the decision was made by a advisory panel, the decision is only of an orientation character.

What is still missing?

In order for Pfizer's vaccine to be given to children ages 5 to 11, it is necessary for the FDA to make a ruling in favor of immunizing. This decision does have an authorization character and should come out within a few days, although there is still no set date for it to happen.

It is quite common for the regulatory body, which is similar to our National Health Surveillance Agency (Anvisa), follow the recommendations issued by its advisory panels. However, FDA approval is not final authorization for a vaccine or drug to be used in a public.

CDC Authorization

After FDA clearance, the Centers for Disease Control and Prevention (CDC) is required to give an opinion on the matter. Only then, the drug is released for use in a certain audience or age group.

Read more:

If all goes as expected, Pfizer's vaccine will be the first that can be used in children ages 5 to 11 in the United States. Currently, only the public over 12 years old of age can be immunized against Covid-19 in US territory.

Street: The Globe

Have watched the new videos on YouTube do Olhar Digital? Subscribe to the channel!